What is HC Wainwright’s Forecast for FULC FY2029 Earnings?
Fulcrum Therapeutics, Inc. (NASDAQ:FULC – Free Report) – Research analysts at HC Wainwright issued their FY2029 EPS estimates for Fulcrum Therapeutics in a report released on Wednesday, February 26th. HC Wainwright analyst A. Fein expects that the company will earn ($0.95) per share for the year. HC Wainwright has a “Neutral” rating and a $4.00 […]
Fulcrum Therapeutics, Inc. (NASDAQ:FULC – Free Report) – Research analysts at HC Wainwright issued their FY2029 EPS estimates for Fulcrum Therapeutics in a report released on Wednesday, February 26th. HC Wainwright analyst A. Fein expects that the company will earn ($0.95) per share for the year. HC Wainwright has a “Neutral” rating and a $4.00 […]
